Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer†

OBJECTIVES: Neoadjuvant therapy has emerged as a favoured treatment paradigm for patients with clinical N2 disease undergoing surgical resection for non-small-cell lung cancer. It is unclear whether such a treatment paradigm affects perioperative outcomes. We sought to examine the National Cancer Da...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Cardiothorac Surg
Hlavní autoři: Yendamuri, Sai, Groman, Adrienne, Miller, Austin, Demmy, Todd, Hennon, Mark, Dexter, Elisabeth, Picone, Anthony, Nwogu, Chukwumere, Dy, Grace K
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Thoracic
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018932/
https://ncbi.nlm.nih.gov/pubmed/29253122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ejcts/ezx406
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky